Vaccine compositions comprising a saponin adjuvant

Details for Australian Patent Application No. 2006325377 (hide)

Owner GlaxoSmithKline Biologicals sa

Inventors Vandepapeliere, Pierre

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006325377

PCT Pub. Number WO2007/068907

Priority 0525321.6 13.12.05 GB; 0609902.2 18.05.06 GB; 0620337.6 12.10.06 GB; 0620336.8 12.10.06 GB

Filing date 12 December 2006

Wipo publication date 21 June 2007

Acceptance publication date 2 February 2012

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/068907 Priority application(s): WO2007/068907

2 February 2012 Application Accepted

  Published as AU-B-2006325377

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006325379-Pattern matching apparatus

2006325359-Anti-myosin Va siRNA and skin depigmentation